
Anna Kathy Aman
Examiner (ID: 18092, Phone: (571)272-4515 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2914, 2973 |
| Total Applications | 3318 |
| Issued Applications | 3249 |
| Pending Applications | 17 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20377638
[patent_doc_number] => 20250360131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-27
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
[patent_app_type] => utility
[patent_app_number] => 19/230051
[patent_app_country] => US
[patent_app_date] => 2025-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19230051
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/230051 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Jun 4, 2025 | Pending |
Array
(
[id] => 20246913
[patent_doc_number] => 20250295782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 19/228293
[patent_app_country] => US
[patent_app_date] => 2025-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19228293
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/228293 | Pharmaceutical compositions comprising meloxicam | Jun 3, 2025 | Issued |
Array
(
[id] => 20246914
[patent_doc_number] => 20250295783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-25
[patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM
[patent_app_type] => utility
[patent_app_number] => 19/228565
[patent_app_country] => US
[patent_app_date] => 2025-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19228565
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/228565 | Pharmaceutical compositions comprising meloxicam | Jun 3, 2025 | Issued |
Array
(
[id] => 20371263
[patent_doc_number] => 12478678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Pharmaceutical compositions comprising meloxicam
[patent_app_type] => utility
[patent_app_number] => 19/228179
[patent_app_country] => US
[patent_app_date] => 2025-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 35
[patent_no_of_words] => 20459
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19228179
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/228179 | Pharmaceutical compositions comprising meloxicam | Jun 3, 2025 | Issued |
Array
(
[id] => 20391719
[patent_doc_number] => 20250367194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
[patent_app_type] => utility
[patent_app_number] => 19/215242
[patent_app_country] => US
[patent_app_date] => 2025-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19215242
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/215242 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | May 20, 2025 | Pending |
Array
(
[id] => 20335328
[patent_doc_number] => 20250339448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-11-06
[patent_title] => METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA
[patent_app_type] => utility
[patent_app_number] => 19/206788
[patent_app_country] => US
[patent_app_date] => 2025-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10263
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19206788
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/206788 | METHODS OF TREATING ISCHEMIC STROKE AT RISK FOR CEREBRAL OR CEREBELLAR EDEMA | May 12, 2025 | Pending |
Array
(
[id] => 20149112
[patent_doc_number] => 20250248950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-07
[patent_title] => USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 19/187858
[patent_app_country] => US
[patent_app_date] => 2025-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1421
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19187858
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/187858 | Use of cannabinoids in the treatment of epilepsy | Apr 22, 2025 | Issued |
Array
(
[id] => 20262916
[patent_doc_number] => 12433884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Compounds and combinations thereof for treating neurological and psychiatric conditions
[patent_app_type] => utility
[patent_app_number] => 19/182463
[patent_app_country] => US
[patent_app_date] => 2025-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 25
[patent_no_of_words] => 59226
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19182463
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/182463 | Compounds and combinations thereof for treating neurological and psychiatric conditions | Apr 16, 2025 | Issued |
Array
(
[id] => 20093320
[patent_doc_number] => 20250223256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => METHODS FOR MAKING AND USING ENDOXIFEN
[patent_app_type] => utility
[patent_app_number] => 19/094756
[patent_app_country] => US
[patent_app_date] => 2025-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -93
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19094756
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/094756 | Methods for making and using endoxifen | Mar 27, 2025 | Issued |
Array
(
[id] => 20401224
[patent_doc_number] => 12491184
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Compositions and methods of use for modified release minoxidil
[patent_app_type] => utility
[patent_app_number] => 19/094716
[patent_app_country] => US
[patent_app_date] => 2025-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 46837
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19094716
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/094716 | Compositions and methods of use for modified release minoxidil | Mar 27, 2025 | Issued |
Array
(
[id] => 20092057
[patent_doc_number] => 20250221993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL
[patent_app_type] => utility
[patent_app_number] => 19/094703
[patent_app_country] => US
[patent_app_date] => 2025-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19094703
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/094703 | COMPOSITIONS AND METHODS OF USE FOR MODIFIED RELEASE MINOXIDIL | Mar 27, 2025 | Pending |
Array
(
[id] => 20315191
[patent_doc_number] => 12453730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-28
[patent_title] => Methods of treatment
[patent_app_type] => utility
[patent_app_number] => 19/087148
[patent_app_country] => US
[patent_app_date] => 2025-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 104292
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19087148
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/087148 | Methods of treatment | Mar 20, 2025 | Issued |
Array
(
[id] => 20385411
[patent_doc_number] => 12485120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Methods of treating disorders using CSF1R inhibitors
[patent_app_type] => utility
[patent_app_number] => 19/079727
[patent_app_country] => US
[patent_app_date] => 2025-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 19
[patent_no_of_words] => 117187
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19079727
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/079727 | Methods of treating disorders using CSF1R inhibitors | Mar 13, 2025 | Issued |
Array
(
[id] => 20039193
[patent_doc_number] => 20250177415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-05
[patent_title] => TREATMENT FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION WITH GUANETHIDINE AND GUANADREL
[patent_app_type] => utility
[patent_app_number] => 19/050547
[patent_app_country] => US
[patent_app_date] => 2025-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19050547
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/050547 | Treatment for heart failure with preserved ejection fraction with guanethidine and guanadrel | Feb 10, 2025 | Issued |
Array
(
[id] => 19968423
[patent_doc_number] => 12337006
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-06-24
[patent_title] => Methods of treating ischemic stroke at risk for cerebral or cerebellar edema
[patent_app_type] => utility
[patent_app_number] => 19/039220
[patent_app_country] => US
[patent_app_date] => 2025-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10256
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19039220
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/039220 | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema | Jan 27, 2025 | Issued |
Array
(
[id] => 20127874
[patent_doc_number] => 12370174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Methods of improving renal function
[patent_app_type] => utility
[patent_app_number] => 18/990351
[patent_app_country] => US
[patent_app_date] => 2024-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 66606
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18990351
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/990351 | Methods of improving renal function | Dec 19, 2024 | Issued |
Array
(
[id] => 20328358
[patent_doc_number] => 12458615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Methods for providing rapid relief of motor fluctuations in a Parkinson's disease patient
[patent_app_type] => utility
[patent_app_number] => 18/949037
[patent_app_country] => US
[patent_app_date] => 2024-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6884
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18949037
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/949037 | Methods for providing rapid relief of motor fluctuations in a Parkinson's disease patient | Nov 14, 2024 | Issued |
Array
(
[id] => 19896808
[patent_doc_number] => 12274702
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Nasal compositions comprising alcaftadine
[patent_app_type] => utility
[patent_app_number] => 18/943210
[patent_app_country] => US
[patent_app_date] => 2024-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3654
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18943210
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/943210 | Nasal compositions comprising alcaftadine | Nov 10, 2024 | Issued |
Array
(
[id] => 19930324
[patent_doc_number] => 12303517
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-05-20
[patent_title] => Oral testosterone therapy
[patent_app_type] => utility
[patent_app_number] => 18/938942
[patent_app_country] => US
[patent_app_date] => 2024-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13338
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18938942
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/938942 | Oral testosterone therapy | Nov 5, 2024 | Issued |
Array
(
[id] => 19784160
[patent_doc_number] => 20250057839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => TREATMENT OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/937891
[patent_app_country] => US
[patent_app_date] => 2024-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18937891
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/937891 | Treatment of prostate cancer | Nov 4, 2024 | Issued |